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Abstract: The inflammatory tumor microenvironment is a fertile niche accelerating prostate cancer
(PCa). We have reported that heme-oxygenase (HO-1) had a strong anti-tumoral effect in PCa.
We previously undertook an in-depth proteomics study to build the HO-1 interactome in PCa. In this
work, we used a bioinformatics approach to address the biological significance of HO-1 interactors.
Open-access PCa datasets were mined to address the clinical significance of the HO-1 interactome in
human samples. HO-1 interactors were clustered into groups according to their expression profile
in PCa patients. We focused on the myxovirus resistance gene (MX1) as: (1) it was significantly
upregulated under HO-1 induction; (2) it was the most consistently downregulated gene in PCa vs.
normal prostate; (3) its loss was associated with decreased relapse-free survival in PCa; and (4) there
was a significant positive correlation between MX1 and HMOX1 in PCa patients. Further, MX1 was
upregulated in response to endoplasmic reticulum stress (ERS), and this stress triggered apoptosis
and autophagy in PCa cells. Strikingly, MX1 silencing reversed ERS. Altogether, we showcase MX1
as a novel HO-1 interactor and downstream target, associated with ERS in PCa and having a high
impact in the clinical setting.
Keywords: heme-oxygenase 1 (HO-1); myxovirus resistance protein (MX1); endoplasmic reticulum
stress; unfolded protein response; prostate cancer
1. Introduction
The principal goal currently within prostate cancer (PCa) research is to unveil markers for the early
detection of aggressive tumors that are predestined to invade and metastasize and to find druggable
targets. Proteomics represents an important tool for the identification of new molecular targets for
PCa-tailored therapy. Towards this end, we previously undertook an in-depth mass spectrometry-based
study to build the heme-oxygenase 1 (HO-1) interactome in PCa. Heme-oxygenase 1, a critical mediator
of cellular homeostasis [1], appears as an interesting target in oncology [2]. Although different roles
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have been attributed to HO-1 and tumor pathology [3], we have shown its anti-tumoral effects in PCa.
This factor was capable of inhibiting cell proliferation, migration, and invasion [4]; it impaired tumor
growth and angiogenesis in vivo and downregulated target genes associated with inflammation [4,5].
Interestingly, we have also found a tight association between HO-1 and the cytoskeletal compartment,
altering adherens junctions and cell-cell zippering in PCa [6–8]. We have established a four molecular
pathway foundation (ANXA2/HMGA1/POU3F1; NFRSF13/GSN; TMOD3/RAI14/VWF; PLAT/PLAU)
behind HO-1 regulation of the tumor cytoskeletal compartments [8].
We propose that HO-1 and its interactors reprogram PCa cells and, in turn, modify the tumor
microenvironment, favoring a less aggressive phenotype. Thus, we were interested in addressing the
clinical significance of HO-1 interactors in PCa. In particular, as HO-1 is a stress response protein [9],
we sought interactors associated with cellular stress.
The constant division of tumor cells represents a challenge given by the restriction in nutrients
and oxygen supplies, supporting the selection of cell variants. This characteristic represents one of the
reasons why proteins display altered expression patterns in cancer.
The functional complexity of the endoplasmic reticulum (ER) can be affected by a number of
factors, both from the cell interior itself and/or from the environment that surrounds it, causing ER
stress (ERS) [10]. Such factors include hypoxia, glucose availability, hypernatremia, redox status,
and calcium levels, which directly impact the correct folding of proteins within the endoplasmic lumen,
thus generating an accumulation of unfolded or misfolded proteins within ER [10]. This event triggers
a specific cellular process in order to reestablish cellular proteostasis, which is known as the response
to misfolded proteins (unfolded protein response (UPR)) [11]. Activation of this mechanism is the
criterion that defines ERS [10]. The suboptimal conditions of the tumor microenvironment are the
main triggers that make UPR activation a vital mechanism for the survival of tumor cells. Several
observations have shown that an aggravated increase in acute stress, as well as the extension in time
of the stressful stimulus represent decisive factors when determining cell destiny regarding death or
survival [12,13].
To explore the contribution of HO-1 interactors associated with ER stress in PCa, we first performed
a thorough bioinformatics analysis to address the role of HO-1 interacting proteins in this disease.
Proteins were clustered into three groups according to their expression profile. In parallel, we carried
out an RNA-seq analysis to compare gene expression profiles between PCa cells over-expressing
HO-1 and their respective controls, to evaluate the ability of HO-1 in regulating the expression at the
transcriptional level of the proteins included in these clusters.
Taking into account all of our results, we focused on the human myxovirus resistance gene (MX1).
This factor is well described as playing a vital role in preventing the replication of various types of RNA
viruses [14–16]. Interestingly, some reports demonstrated that cells infected with the Influenza virus
increased apoptosis mediated by ERS [14]. Hence, we sought to assess whether there was an association
between MX1 and ERS in PCa and, in turn, whether this association was linked to pro-apoptotic or
pro-autophagic events. Further, we analyzed HMOX1, MX1, and ERS as risk predictors of clinical
outcome in PCa.
2. Materials and Methods
2.1. Cell Culture, Treatments, Reagents, and Antibodies
PC3 cells were obtained from the American Type Culture Collection (Manassas, VA, USA) and
cultured with RPMI 1640 culture medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% v/v
fetal bovine serum (FBS) (Internegocios, Buenos Aires, Argentina), penicillin 100 U/mL, streptomycin
100 µg/mL, and amphotericin 0.5 µg/mL. Hemin was obtained from SIGMA-Aldrich (St. Louis, MO,
USA). For treatments, cells were incubated 24 h in RPMI media containing 10% FBS and antibiotics
and then were exposed to hemin (80 µM, 24 h). Thapsigargin was obtained from Sigma-Aldrich and
dissolved in dimethyl sulfoxide (DMSO) and phosphate-buffered saline (PBS). For treatments, cells
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were incubated in complete RPMI media and treated with thapsigargin 0.1 µM or 0.25 µM for 24 h.
Interferon gamma (INFγ) protein was obtained from ImmunoTools (Friesoythe, Germany). PC3 cells
were treated with INFγ, 500 U/mL, for 18 or 24 h.
Mouse anti-human HO-1 monoclonal antibody and rabbit anti-MX1 antibody were obtained from
Abcam (Cambridge, UK). Mouse anti-human β-actin antibody, rabbit anti-LC3, and rabbit anti-GADPH
antibodies were obtained from Cell Signaling (Danvers, MA, USA). Horseradish peroxidase (HRP)
conjugated anti-mouse secondary antibody was obtained from Cell Signaling. Secondary antibodies
conjugated to Alexa 555 and Alexa 647 fluorophores were obtained from Molecular Probes, Invitrogen.
2.2. Plasmids and Transient Transfections
PC3 cells were transiently transfected for 48 h with HO-1 expression plasmids (p3xFLAGHO-1
or pcDNA3HO-1) or empty vectors as controls (p3xFLAG or pcDNA3), as previously described [8].
Cells cultured in 10 cm plates were transfected using 10 µg of plasmid and 20 µL of polyethylene glycol
(PEI) in a final volume of 200 µL of RPMI 1640 culture medium. Transfections were performed on
plates with 3 mL of RPMI 1640 without FBS or antibiotics. Five hours post-transfection, the culture
medium was replaced by RPMI 1640 complete with 10% v/v FBS and antibiotics in the previously
mentioned concentrations.
2.3. RNA Isolation, c-DNA Synthesis, and Quantitative Real-Time Polymerase Chain Reaction
Total RNA was isolated with Quick-Zol (Kalium technologies, Buenos Aires, Argentina) according
to the manufacturer’s protocol. cDNAs were synthesized with the RevertAid Premium First Strand
cDNA Synthesis Kit (Fermentas, Waltham, MA, USA) and used for real-time PCR amplification
with Taq DNA Polymerase (Invitrogen, Waltham, MA, USA) in a QuantStudio 3 Real-Time PCR
System (Thermo Fisher Scientific, Waltham, MA, USA). PPIA was used as an internal reference gene.
The data obtained were analyzed using the method of 2-∆∆CT [17]. Primers used for each gene were
as follows (5′-3′): MX1 Fw: AGGACCATCGGAATCTTGAC, Rv: TCAGGTGGAACACGAGGTTC;
HSPA5 Fw: ACCGCTGAGGCTTATTTGGGA, Rv: CGTCTTTGGTTGCTTGGCGT;
XBP1 Fw: TGGATGCCCTGGTTGCTGAA, Rv: GCACCTGCTGCGGACTCA; DDIT3
Fw: GCAGCGACAGAGCCAAAATC, Rv: GCTTTCAGGTGGTGATGTATG; PPIA Fw:
GGTATAAAAGGGGCGGGAGG, Rv: CTGCAAACAGCTCAAAGGAGAC.
2.4. RNA Sequencing
RNA-seq was performed as previously described [8].
2.5. Immunofluorescence Assay
Cells were seeded in 12 well plates at a density of 1 × 105 cells per well on coverslips overnight.
After cells were transiently transfected with pcDNA3HO-1 or empty vector, cells were fixed in ice-cold
methanol for 20 min at 4 ◦C and permeabilized with 0.1% Triton X (v/v) in PBS for 5 min at room
temperature. After washing twice with PBS, cells were blocked with 3% (m/v) bovine serum albumin
(BSA)/PBS for 1 h at room temperature. Cells were incubated overnight at 4 ◦C with anti-MX1 and
HO-1 antibodies diluted 1:200 in 3% (m/v) BSA/PBS. Negative controls were carried out using PBS
instead of primary antibodies. Cells were washed with PBS and incubated with fluorescent secondary
antibodies for 1 h at room temperature, then stained with DAPI, and imaged by confocal laser scanning
microscopy, performed with an Olympus Fluo View FV 1000 microscope, using an Olympus 60X/1.20
NA UPLAN APO water immersion objective.
2.6. Protein Extraction, Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis and Western Blot
Total cell lysates and immunoblot analysis were carried out as previously described [18]. Briefly,
cells were lysed with RIPA buffer (Tris HCl 50 mM pH 7.4; NaCl 150 mM; ethylenediaminetetraacetic
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acid (EDTA) 20 mM pH 8; sodium deoxycholate 1%; SDS 0.1%; Triton X-100 1%, 1 mM Na3VO4, 20 mM
NaF, and 1 mM Na4 P2O7, pH 7.9) and homogenized. After 20 min of incubation at 4 ◦C, lysates were
centrifuged at 12,000× g for 20 min at 4 ◦C and the supernatant kept at −80 ◦C. Lysates containing equal
amounts of proteins (60 µg) were resolved on 7.5–12.5% Sodium Dodecyl Sulphate-Polyacrylamide Gel
Electrophoresis (SDS–PAGE) depending on the molecular weight of the proteins under study. Page
Ruler Plus Prestained Protein Ladder (Fermentas) was used for the estimation of molecular weight.
Proteins were blotted to a Hybond-ECL nitrocellulose membrane (GE Healthcare, Little Chalfont, UK).
Membranes were blocked with 5% dry non-fat milk in TBS containing 0.1% Tween 20 (TBST) for 1 h at
room temperature and incubated with primary monoclonal antibodies diluted in TBST (overnight;
at 4 ◦C). Membranes were then washed with TBST (10 min; three times) and incubated with horseradish
peroxidase-labelled secondary antibody (1 h at room temperature).
2.7. Apoptosis Analysis by Flow Cytometry
The FITC Annexin V Apoptosis Detection Kit II (BD Pharmingen, San Jose, CA, USA) was used
to assay thapsigargin-induced apoptosis in PC3 cells, according to the manufacturer’s instructions.
Briefly, after treatment, cells were washed twice with cold 1× PBS and resuspended in binding buffer
1× at a concentration of 1 × 106 cells/mL. From this suspension, one-hundred microliters were labeled
with FITC Annexin V and propidium iodide (IP) and incubated for 15 min at room temperature in
the dark. Finally, four-hundred microliters of binding buffer 1× were added and analyzed by flow
cytometry (Attune™NxT Flow Cytometer, Thermo Fisher Scientific) in the corresponding channels
(Ex/Em: 495 nm/519 nm and 543 nm/614 nm), and the results were analyzed with FlowJo 8.7 software.
For the non-specific label control, between 5 and 15 µg of the purified recombinant Annexin V protein
were added to the cell suspension and incubated at room temperature for 15 min before proceeding
with the labeling step (FITC + IP).
2.8. siRNA Transfection
PC3 cells were transfected with ON-TARGETplus SMARTpool siRNA (Dharmacon; Pittsburgh,
PA, USA, cat# L-011735-00-0005) to knock down MX1 expression or with a non-specific sequence siRNA
(siRNA scrambled) as a negative control (ON-TARGETplus siRNA, Dharmacon, cat# D-001810-01-05).
An amount of 3 × 105 PC3 cells was plated in six well multiwell plates until 50% of confluence.
The culture medium in each plate was then replaced with 1.8 mL of complete RPMI 1640 medium
and transfected with the corresponding siRNA in a concentration of 25 nM using Lipofectamine LTX
(Invitrogen). Forty-eight hours later, thapsigargin 0.25 µM was added for 24 h until RNA extraction.
2.9. Statistical Analysis
The t-test or ANOVA with the Tukey post-test was used to ascertain statistical significance with a
threshold of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
2.10. Bioinformatics Analysis
2.10.1. Oncomine Meta-Analysis in Prostate Cancer Patients
We searched the public cancer microarray database Oncomine (http://www.oncomine.org) to
identify expression microarrays that compared expressions in prostatic adenocarcinoma vs. prostate
gland. To be included in our study, a dataset was required to (1) be generated from human prostate
tumors and (2) compare prostate adenocarcinoma vs. normal prostate gland. Differential genes
were considered when: (1) they presented a p-value < 0.05 and (2) had an increase or decrease in
expression ≥ 1.5 times. Although the p-value criterion was strict for the dataset selection, some genes
were considered even if the fold change or the gene rank was <1.5 or >10%, respectively, when the
gene showed a significant over- or under-expression. Genes were ranked by their p-value for every
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analysis scoring a gene rank. The median rank was the median p-value rank across datasets, for each
gene assessed.
Search/study selection: We performed a search for each HO-1 interactor protein. The resulting
studies were analyzed on the basis of healthy prostate gland vs. prostate adenocarcinoma. The cited
literature was reviewed to confirm that the analysis was as documented in the Oncomine database.
All the selected papers are included in Table 1 of the Results Section.
Table 1. Meta-analysis of multiple microarray datasets for HO-1-interacting proteins. Expression
microarray studies selected from the Oncomine platform (http://www.oncomine.org) comparing
prostate adenocarcinoma vs. normal prostate. N/A = not available.





1 Arreduani Prostate HG U133 Plus 2.0 Array 19,574 21 GSE55945
2 Grasso Prostate Agilent Human Genome 44K 19,189 122 GSE35988
3 Holzbeierlein Prostate HG U95A-Av2 Array 8603 54 N/A
4 Lapointe Prostate Undefined Platform 10,166 112 GSE3933
5 LaTulippe Prostate HG U95A-Av2 Array 8603 35 GSE68882
6 Liu Prostate HG U133A Array 12,624 57 N/A
7 Luo Prostate Hu35k (A-D) and HGU95A-Av2 array 15,302 30 GSE68545
8 Magee Prostate HumanGeneFL Array 5338 15 N/A
9 Singh Prostate HG U95A-Av2 Array 8603 102 GSE68907
10 Taylor Prostate Undefined Platform 22,238 185 GSE21032
11 Tomlins Prostate Undefined Platform 10,656 101 GSE6099
12 Vanaja Prostate HG U133(A-B) Array 17,779 40 N/A
13 Varambally Prostate HG U133 Plus 2.0 Array 19,574 19 GSE3325
14 Wallace Prostate HG U133 2.0 Array 12,603 89 GSE6956
15 Welsh Prostate HG U95A-Av2 Array 8603 34 N/A
16 Yu Prostate HG U95A-Av2 Array 8603 112 GSE68555
2.10.2. RNA-Seq Gene Expression and Correlation Analysis in Prostate Cancer Patients
For gene expression and correlation analysis, we used the dataset from the Prostate
Adenocarcinoma Project of The Cancer Genome Atlas (TCGA-PRAD; http://cancergenome.nih.gov).
This study includes RNA-seq data from 497 prostate tumor samples and normal adjacent to tumor
tissue, measured by massively parallel sequencing (Illumina HiSeq).
For transcriptomics data derived from normal tissues, we browsed the Genotype-Tissue Expression
(GTEx) project (2013) (https://gtexportal.org/), a collection of 54 non-diseased tissues sites across 1000
healthy donors. For our study, we used RNA-seq gene expression data of prostate samples (n = 100).
2.10.3. Gene Expression Microarray and Relapse-Free Survival in Prostate Cancer Patients
To study the impact of expression levels on relapse-free survival (RFS) for PCa patients, one
dataset was selected according to the following criteria: (1) the study included gene expression and
clinical data for each patient with ≥ 5 years of follow-up; (2) the study consisted of ≥60 samples; and (3)
the study was published and available in public repositories.
We used the dataset from Ross-Adams 2015 (GSE70770) [19] GPL10558 series available in gene
expression omnibus (GEO). It includes information of a prostate cancer patient cohort with 206 samples
from men who had undergone radical prostatectomy and clinical follow-up of eight years, including
relapse information (biochemical relapse). Biochemical relapse was defined according to the European
Guidelines as a prostate specific antigen (PSA) persistent rise above 0.2 ng/mL). Tumor sample
expression of 31,000 transcripts was measured by 47,000 probes using the Illumina HumanHT-12
V4.0 platform.
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2.10.4. cBioPortal Exome Analysis in Prostate Cancer Patients
We used cBioPortal (https://www.cbioportal.org/), an open source cancer genomics data platform,
created by the Memorial Sloan-Kettering Cancer Center (MSKCC), to analyze the most common
mutations, copy-number alterations, and gene expression of MX1 and HMOX1 in PCa patients
(11 datasets, n = 3211 samples; last accessed April 2020). The criteria used in order to include datasets
in our analysis were as follows: (1) type of cancer: Prostate adenocarcinoma or metastasis; (2) the study
must be published; and (3) the study consists of a sample number > 60.
2.10.5. Statistical Analysis
Stata software (StataCorp LLC, College Station, TX, USA) was used to explore patients’ RFS, and
survminer R package [20] was used to generate Kaplan–Meier (KM) curves. To find the cutoff value to
stratify patients into two groups based on the gene expression levels, we used the minimal p-value
approach from the Cutoff Finder tool [21]. For univariable analyses of prognostic factors, the log-rank
test and Cox proportional hazard model regression were employed. The hazards ratio (HR) indicates
the probability of relapse of a patient with high gene expression with respect to one with low gene
expression, considering HR=1 for the latter case. Correlation analysis between HMOX1 and MX1
was performed using Graph Pad Software. The Pearson correlation coefficient was determined for all
analyses. Statistical significance was set at p < 0.05. For copy-number alterations and gene expression
analysis, ANOVA followed by Tukey post tests were performed to assess statistical significance with a
threshold of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
3. Results
3.1. Clinical Relevance of the HO-1 Interactome in Prostate Cancer
The molecular mechanisms underlying the pathogenesis of cancer-associated inflammation are
intricate and represent a complex dialogue between the tumor and the microenvironment. As mentioned
previously, HO-1 induction represents a critical event in cellular responses to pro-oxidative and
pro-inflammatory insults [22]. HO-1 has been proposed to act as a biosensor regulating cell fate [23].
The current literature evidences that HO-1 has a role beyond its catalytic activity, participating in a
wide variety of cellular processes that inhibit prostate tumor progression [1]. For this reason, we set
out to identify HO-1-associated proteins and assess their clinical significance in PCa. We previously
described the HO-1 interactome in PCa through a proteomics approach, identifying HO-1 molecular
partners [8]. To address the clinical relevance of the HO-1 interactome in PCa, we searched the public
cancer microarray database Oncomine (http://www.oncomine.org). This tool enabled us through
pre-computed analyses to identify whether these genes had a high statistical significance for over-
or under-expression in prostate adenocarcinoma vs. normal prostate gland. At the time of analysis,
it harbored a total of 715 datasets and 86,763 human patient samples. We considered 16 datasets that
met our eligibility criteria. Table 1 outlines the datasets selected, the total number of patients assessed
(n = 1045), and the number of genes analyzed in each microarray. We elaborated a transcriptomic profile
for each of the HO-1 interactors and classified them into three different clusters (A, B, or C) according
to the following expression profiles (Figure 1A): Cluster A, genes that were over- or under-expressed in
approximately 60% of datasets; Cluster B, genes that were over- or under-expressed in approximately
50% of datasets; Cluster C, genes that were over- or under-expressed in similar percentages of datasets
(Figure 1A). Cluster A rendered the following genes: NOA1, CBX3, RCC1, EEF2, ASPH, SQSTM1,
TMOD3, GSN, HSPB1, and ANXA2 (Figure 1B). The pie charts represent the percentage of datasets
where the gene under study was over-expressed in PCa vs. normal prostate (red) or under-expressed
in the same comparison (blue) (Figure 1B). Cluster B included: TOP1, PDCD5, THRAP1, SLC12A7,
PURA, RPA1, SFRS3 and MX1 (Figure 1B). Cluster C included: ZC3HAV1, AHCTF1, TIMM44, KHSRP,
MATR3, SIPA1L1, FTSJ3, NAP1L1, PRDX2, CACYBP, and ARNTL2 (Figure 1B). The meta-analysis
combining data from the independent datasets assessed showed that for prostate adenocarcinoma vs.
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normal prostate gland, Cluster A and B genes lied within 35% of the most consistently high or low
expressed genes across this comparison (Figure 1C). We also assessed all clusters’ expression profiles
across The Human Protein Atlas platform (https://www.proteinatlas.org/). Although a few samples
were available for prostate adenocarcinoma, we could observe a positive correlation for NOA, RCC1,
TMOD3, HSPB1, ASPH, SQSTM1, and ANXA2 from Cluster A and TOP1, PDCD5, THRAP3, and MX1
from Cluster B (Supplementary Figure S1A).
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expression profile in PCa patients in the Oncomine platform (n = 1045): Cluster A (aquamarine), Cluster
B (red), Cluster C (yellow), and unclustered proteins (grey). Cluster A: genes that presented over-
or under-expression in approximately 60% of the analyzed studies. Cluster B: genes that presented
over- or under-expression in approximately 50% of the studies analyzed. Cluster C: genes expressed
in similar proportions of over- or under-expression in the analyzed studies. (B) HO-1 interactor
proteins were grouped according to their genetic expression profile. The graph shows the percentage
of studies reporting gene under-expression (blue), over-expression (red), or without changes (gray)
in each study analyzed in Oncomine (n = 1045). (C) Summary table showing the median rank and
p-value for genes in Clusters A and B. (D) Gene expression analysis for genes in Clusters A and B
comparing tumor vs. normal adjacent to tumor tissue, using the TCGA-Prostate Adenocarcinoma
Project (PRAD) expression dataset (n = 497). The color code indicates no change in gene expression
(white), over-expression (red), or under-expression (blue) for each gene. The intensity of the color
is directly proportional to the gene’s expression fold change. The p-value for each gene is indicated
in the third column. (E) The table summarizes the global analysis of the HO-1 interactome genes
corresponding to Clusters A and B in Oncomine (16 datasets, n = 1045) and TCGA-PRAD (n = 497).
The arrows indicate over- (red) or under-expression (blue) when comparing PCa vs. normal or normal
adjacent to tumor tissue. Meta-analyses determined a median rank (position) for each gene assessed
across all datasets. N/A = not available.
In parallel, we examined gene expression for Clusters A and B using the data from the Prostate
Adenocarcinoma Project of The Cancer Genome Atlas (TCGA-PRAD, n = 497) [24]. This dataset
allowed us to evaluate gene expression profiles for PCa vs. normal adjacent to tumor tissue (Figure 1D).
Values greater than one represent gene induction (red), while values lower than one represent
gene downregulation (blue). Results showed a significant dysregulation of selected genes in tumor
compared with normal adjacent to tumor tissues: ANXA2 (fold change = 0.496; p = 4.48E-19), GSN
(fold change = 0.533; p = 3.40 × 10−21), MX1 (fold change = 0.578; p = 1.04 × 10−7), HSPB1 (fold
change = 0.584; p = 9.95 × 10−24), and ASPH (fold change = 0.613; p = 1.87 × 10−13); EEF2 (fold
change = 2.43; p = 1.31× 10−73), NOA1 (fold change = 1.762; p = 9.53 × 10−40), and RCC1 (fold
change = 1.740; p = 6.48 × 10−31). Although the comparisons made in TCGA-PRAD and Oncomine
were not exactly performed on the same tissues, some synchronicity could be observed between the
expression profiles in both analyses for the genes studied (Figure 1E). Genes CBX3, RCC1, TMOD3,
and NOA1 (Cluster A) and TOP1, PDCD5, and THRAP3 (Cluster B) were upregulated for both datasets
in PCa tissue vs. normal gland or normal adjacent to tumor tissue. Genes ASPH, HSPB1, SQSTM1,
ANXA2, and GSN (Cluster A) and PURA and MX1 (Cluster B) were downregulated for both datasets
in PCa tissue vs. normal gland or normal adjacent to tumor tissue (Figure 1F).
3.2. Transcriptomic Analysis of HO-1 Interactors and Risk of Relapse in Prostate Cancer Patients
To evaluate the relapse-free survival (RFS) time in PCa patients, associated with changes in
the expression of Cluster A and B genes, we carried out an analysis using the Ross–Adams dataset
(GSE70770) [19] (n = 206), which gathers expression and clinical data from PCa patients who had
undergone radical prostatectomy. Kaplan–Meier (KM) curves were performed taking the low expression
group as the control. Results showed that RFS was significantly lower in patients who had low
expression of TMOD3, EEF2, ASPH, HSPB1, SQSTM1, ANXA2, GSN, TOP1, THRAP3, SLC12A7,
PURA, and MX1 or high expression of RCC1, PDCD5, RPA1, and SFRS3 (Table 2 and Supplementary
Figure S1B). When compiling all the expression and RFS data, we could sub-classify genes with high
expression in PCa vs. normal gland or normal adjacent to tumor tissue and significantly decreased RFS
(RCC1 and PCDC5) or with low expression in PCa and decreased RFS (ASPH, GSN, HSPB1, SQSTM1,
ANXA2, MX1, and PURA) (Table 2, white dots). In summary, the results evidenced how transcript
dysregulation of these HO-1 interactors was associated with a change in RFS, highlighting their clinical
importance for PCa.
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Table 2. General comparative summary of gene expression and the effects on relapse-free survival (RFS).
The table summarizes the global analysis of the HO-1 interactome genes corresponding to Clusters A
and B using Oncomine (16 datasets, n = 1045) and TCGA-PRAD (n = 497). The arrows indicate over-
(red) or under-expression (blue) when comparing PCa vs. normal or normal adjacent to tumor tissue.
Meta-analyses determined a median rank (position) for each gene assessed across all datasets. RFS
associated with the gene expression profiles of Clusters A and B are shown for the Ross–Adams dataset
(GSE70770) (n = 206). All comparisons considered low expression patients as the reference group. HR:
hazards ratio. N/A: not available. Genes selected for further analysis are highlighted with * next to
their gene symbol.
EXPRESSION SURVIVAL



















Biomolecules 2020, 10, x FOR PEER REVIEW 10 of 24 
reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
  EXPRESSION SURVIVAL 






























































































 1,581 (top 
35%) 





































































































3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparative RNA-seq analysis between PC3 cells over-
expressing HO-1 and controls [8], we found that HO-1 induction triggered the alteration of key 
cytoskeletal genes leading to a more adhesive and less invasive phenotype, further supporting its 
anti-tumoral function in PCa [8]. Here, we assessed whether HO-1 was capable of modulating the 
gene expression of the selected HO-1 interactors (Table 2, asterisks). Results showed that when PC3 
cells were transiently transfected with the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), there was a significant change in the expression profile of MX1 (Figure 2A). The rest of 
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparative RNA-seq analysis between PC3 cells over-
expressing -  a  ontrols [8], we found that HO-1 induction triggered the alteration of key 
cytoskeletal genes leading to a more adhesive and less invasive phenotype, further supporting its 
anti-tumoral func ion in PCa [8]. Here, we assessed whet er HO-1 was capable of modulating the 
gene expression of th  selected HO-1 interactors (Table 2, asterisks). Results showed that when PC3 
cells were transiently transfect d wi h the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), there was a significant change in the expres ion profile of MX1 (Figure 2A). The rest of 
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
1.312 8.67 × 10−12 0.085 0.65 (0.4–1.06)
RCC1 *
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparativ  RNA-seq analysis b tween PC3 cel s over-
expressing HO-1 and controls [8], w  found that HO-1 nduction trigger d the alteration of key
cytoskeletal ge es leading to a more adhesive and less invasiv  ph notype, further supporti g it
anti-tumoral function in PCa [8]. Here, we ass ssed wh ther HO-1 was ca able of modulating the
gene expression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at when PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
487
(top 15%) 0.012
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work sh wing a comparativ RNA-seq analysis b tween PC3 cells over-
expre ing -  a  ontrols [8], w  found that HO-1 induction triggered the alteration of key
cytoskeletal ge es lead ng to a more adhesive nd l ss invasive phenotype, further supporti g its
anti-tumoral func ion in PCa [8]. Here, we assessed whet er HO-1 was ca able of modulating the
ne expr ssion of th  selected HO-1 i te actors ( able 2, aste isks). Results showed that when PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expres ion profile of MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
1.74 6.48 × 10−31 0.034 4.85 (1.20–2.09)
TMOD3
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparativ  RNA-seq analysis b twe n PC3 cel s over-
expressing HO-1 and co trols [8], w  found that HO-1 nducti n trigger d  alteration of key
cytoskeletal g es leadin  to a more adhesive and les nvasiv  ph notype, further supporti g it
anti-tumor l function in PCa [8]. Here, w  ass ssed wh ther -1 was ca able of modulati g th
gene ex ression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at w e  PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
2035
(top 22%) 0.016
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work sh wing a comparative RNA-seq analysis b tween PC3 cells over-
expr ing -  a  o trols [8], w found that HO-1 inducti n triggered the alteration of key
cytoskeletal g es lead n  t  a more adhesive nd l s  nvasive phenotype, further supporti g its
anti-tumor l func ion in PCa [8]. Here, we as essed whet er -1 was ca able of modulating th
ne ex r ssio  of th  selected HO-1 i te ac ors ( able 2, aste isks). Results showed that w en PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expres ion profile of MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
1.152 9. 3 × 10−0 0.001 0.42 (0.26–0.69)
NOA1
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previou work showing a comparativ  RNA-seq a alysis b twe n PC3 cel s over-
expressing HO-1 and co rols [8], w  found that HO-1 nducti n trigger d  alteration of key
cytoskelet l g es leading to a more adhesive an  les nv siv  ph otype, further supporti g it
anti-tumo l fu ction in PCa [8]. Here, w  ass s ed wh ther -1 was ca able f modul ti g th
gene ex ression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at w e  PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
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(top 3%) 3.76 × 10
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previ u work sh wing a comparative RNA-seq analysis b tween PC3 cells over-
expr ing -  a o rols [8], w found that HO-1 inducti n triggered the alteration of key
cytoskelet l g es lead ng t  a more adhesive n  l s  nv sive phe otype, further supporti g its
anti-tumo l fu c i n in PCa [8]. Here, we as es ed whet er -1 was ca able f modulating th
ne ex r ssio  of th  selected HO-1 i te ac ors ( able 2, aste isks). Results showed that w en PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expres ion profile of MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
1.762 9.53 × 10−40 . . . . . .
EEF2
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reference group. HR: hazards rat o. N/A: not available. Genes selected for further analy is are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparative -seq analysis between PC3 cells over-
expressing HO-1 and controls [8], we found that HO-1 induction triggered the alteration of key 
cytoskeletal gene  leading to a more adhesive and less invasive phe type, further supporting i s 
anti-tumoral function in PCa [8]. Here, we assessed whether HO-1 was capable of modulating the 
gene expression of the selected  i ractors (Table 2, asterisks). Results showed that when PC3 
cells were transiently transfected with the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), the  was a significant cha ge in the exp ession profile f MX  (Figure 2A). Th  rest of 
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as d wnregulated in PCa co pared to normal gland a d was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
299
(top 24%) 1.06 × 1
−05
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previ u work sh ing a ative RNA-seq analysis b tween PC3 cells ver-
expr ing HO-1 and co rols [8], w fou d that HO-1 inducti n trigg red the alteration of key
cytoskelet l g es lead ng t  a more adhesive n  l s  nv sive phe otype, further supporti g its
anti-tumo l fu cti n in PCa [8]. Here, we as es ed whether -1 was ca able f modulating th
ne ex r ssio  of the selected HO-1 i te ac ors ( able 2, aste isks). Results showed that w en PC3
cells were tra i tly tra sfected w th the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
2.43 .31 × 1 −73 0.00 2 0.30 (0.15–0.59)
ASPH *
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous w rk showing a co parativ -seq analysis b twe n PC3 cells ov r-
expressing HO-1 and controls [8], w  found that HO-1 induction triggered the alteration of key
cytoskeletal ge e  leading to a more adhesive and less invasive phe type, further supporti g i s
anti-tumoral function in PCa [8]. Here, we assessed whether HO-1 was ca able of modulating the
gene expression of the selected  i ractors (Table 2, aste isks). Results showed that when PC3
cells were tran i ntly tra sfected with the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), the  was a si nificant cha ge in the exp ession profile f MX  (Figure 2A). Th  rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa co pared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
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(top 9%) 0.003
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous w rk sh wing a comparative R -seq analysis between PC3 cells over-
expre ing -  a  ontrols [8], we found that HO-1 induction triggered the alteration of key 
cytoskeletal gen  lead ng o a more adhesive nd l ss invasive phe type, further supporting its 
anti-tumoral func ion in PCa [8]. Here, we assessed whet er HO-1 was capable of modulating the 
ne expr ssion of th  selected  i actors ( able 2, asterisks). Results showed that when PC3 
cells were tra sie tly transfect d w h the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), the  was a significant ch ge n the exp es ion profile f MX  (Figure 2A). The rest of 
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as d wnregulated in PCa compared to normal gland a d was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
0.613 .87 × 1 −13 0. 01 0.34 (0.18–0.66)
HSPB1*
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous w rk showing a co parativ -seq analysis b twe n PC3 cel s ov r-
expressing HO-1 and co trols [8], w  found that HO-1 nducti n trigger d the alteration of key
cytoskeletal g e  leadin  to a more adhesive and les nvasiv  ph type, further supporti g i
anti-tumor l function in PCa [8]. Here, we ass ssed wh ther -1 was ca able of modulating th
gene ex ression of the selected  i ractors (Table 2, aste i ks). Results showed at w en PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). Th  rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
182.5
(top 11%) 1.06 × 1
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous w rk sh wing a comparative R -seq analysis b tween PC3 cells over-
expr ing -  a  ontrols [8], w found that HO-1 induction triggered the alteration of key
cytoskeletal g  lead ng o a more adhesive nd l ss invasive phe type, further supporti g its
anti-tumoral func ion in PCa [8]. Here, we as essed whet er HO-1 was ca able of modulating the
ne expr ssio  of th  selected i ac ors ( able 2, aste isks). Results showed that when PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), the  was a si nificant ch ge n the exp es ion profile f MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
0.584 9.95 × 1 −24 0. 01 0.36 (0.20–0.66)
SQSTM1 *
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
  EXPRESSION SURVIVAL 









































































798 (to  
9 ) 



















 1,581 (top 
35 ) 





































































1,280 (to  































3.3. mRNA Expression Pr files of HO-1 Interactors under Genetic Inducti n of HO-1 
In our previou w rk showing a co parativ NA-seq analysis b twe n PC3 cel s ov r-
expressing HO-1 and co rols [8], w  found that HO-1 nducti n trigger d  alteration of key
cytoskelet l g e  leading to a more adhesive an  les nv siv  ph type, further supporti g i
anti-tumo l fu ction in PCa [8]. Here, w  ass s ed wh ther -1 was ca able f modulati g th
gene ex ression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at w e  PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
1581
(top 35%) 0.003
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expr ssion Pr files of HO-1 Interactors under Genetic Induction of HO-1 
In our previ us w rk sh wing a comparative R -seq analysis b tween PC3 cells over-
expr ing -  a o trols [8], w found that HO-1 inducti n triggered the alteration of key
cytoskeletal g  lead n  o a more adhesive nd l s  nvasive phe type, further supporti g its
anti-tumor l func i n in PCa [8]. Here, we as essed whet er -1 was ca able of modulating th
ne ex r ssio  of th  selected i ac ors ( able 2, aste isks). Results showed that w en PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expres ion profile of MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
0.961 9.39× 1 − 1 0. 09 0.40 (0.2–0.79)
ANXA2 *
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their g  symbol. 
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3.3. mRNA Expression Pr files of HO-1 Interactors under Genetic Inducti n of HO-1 
In our previou w rk showing a ativ RNA-seq a alysis b twe n PC3 cel s v r-
expressing HO-1 and co rols [8], w  found that HO-1 nducti n trigg r d  alteration of key
cytoskelet l g es leading to a more adhesive an  les nv siv  ph otype, further supporti g i
anti-tumo l fu ction in PCa [8]. Here, w  ass s ed wh ther -1 was ca able f modul ti g th
gene ex ression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at w e  PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
133
(top 16%) 0.003
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gen  symbol. 
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3.3. mRNA Expr ssion Pr files of HO-1 Int ractors under Genetic Induction of HO-1 
In our previ u w rk sh ing a comparative RNA-seq analysis b tween PC3 cells over-
expr ing -  a o rols [8], w fou d that HO-1 inducti n triggered the alteration of key
cytoskelet l g e  lead ng t  a more adhesive n  l s  nv sive phe type, further supporti g its
anti-tumo l fu c i n in PCa [8]. Here, we as es ed whet er -1 was ca able f modulating th
ne ex r ssio  of th  selected HO-1 i te ac ors ( able 2, aste isks). Results showed that w en PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expres ion profile of MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
0.496 4. 8 × 1 −19 0. 01 0.40 (0.23–0.70)
GSN *
Biomolecules 2020, 10, x FOR PEER REVIEW 10 of 24 
reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expression P files of HO-1 In eractors under Gene ic Inducti n of HO-1
In our previou work showing a ativ  RNA-seq a alysis b twe n PC3 cel s v r-
expressing HO-1 and co rols [8], w  found that HO-1 nducti n trigg r   alter tion of key
cytoskelet l g es leading to a more adhesive an  les nv siv  ph otype, further supporti g it
anti-tumo l fu ction in PCa [8]. Here, w  ass s ed wh ther -1 was ca able f modul ti g th
gene ex ression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at w e  PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
586.5
(top 10%) 0. 05
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reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
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3.3. mRNA Expr ssion P files of HO-1 In ractors und r Genetic Induction of HO-1
In our previ u w rk sh ing a ative RNA-seq analysis b tween PC3 cells ver-
expr ing -  a o rols [8], w fou d that HO-1 inducti n trigg red the alteration of key
cytoskelet l g es lead ng t  a more adhesive n  l s  nv sive phe otype, further supporti g its
anti-tumo l fu c i n in PCa [8]. Here, we as es ed whet er -1 was ca able f modulating th
ne ex r ssio  of th  selected HO-1 i te ac ors ( able 2, aste isks). Results showed that w en PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expres ion profile of MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
0.533 3.4 × 1 −21 0. 01 0.27 (0.12–0.60)
B
TOP1
Biomolecules 2020, 10, x FOR PEER REVIEW 1  of 24 
reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
highlighted with a white dot next to their gene symbol. 
  EXPRESSION SURVIVAL 


























8  (top 
0  
4.21 ×  1.312 















, 35 p 
2  



















10−05  2.43 
.31  

























 1,581 (top 
35%) 





































































































3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparative RNA-seq analysis between PC3 cells over-
expressing HO-1 and controls [8], we found that HO-1 induction triggered the alteration of key 
cytoskeletal genes leading to a more adhesive and less invasive phenotype, further supporting its 
anti-tumoral function in PCa [8]. Here, we assessed whether HO-1 was capable of modulating the 
gene expression of the selected HO-1 interactors (Table 2, asterisks). Results showed that when PC3 
cells were transiently transfected with the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), there was a significant change in the expression profile of MX1 (Figure 2A). The rest of 
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparative RNA-seq analysis between PC3 cells over-
expressing -  a  ontrols [8], we found that HO-1 induction triggered the alteration of key 
cytoskeletal genes leading to a more adhesive and less invasive phenotype, further supporting its 
anti-tumoral func ion in PCa [8]. Here, we assessed whet er HO-1 was capable of modulating the 
gene expression of th  selected HO-1 interactors (Table 2, asterisks). Results showed that when PC3 
cells were transiently transfect d wi h the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), there was a significant change in the expres ion profile of MX1 (Figure 2A). The rest of 
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
.468 5.58 × 10−14 0. 05 0.48 (0.29–0.80)
PDCD5 *
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparativ  RNA-seq analysis b tween PC3 cel s over-
expressing HO-1 and controls [8], w  found that HO-1 nduction trigger d the alteration of key
cytoskeletal ge es leading to a more adhesive and less invasiv  ph notype, further supporti g it
anti-tumoral function in PCa [8]. Here, we ass ssed wh ther HO-1 was ca able of modulating the
gene expression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at when PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
8 6.5
(top 22%) 0. 11
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work sh wing a comparativ RNA-seq analysis b tween PC3 cells over-
expre ing -  a  ontrols [8], w  found that HO-1 induction triggered the alteration of key
cytoskeletal ge es lead ng to a more adhesive nd l ss invasive phenotype, further supporti g its
anti-tumoral func ion in PCa [8]. Here, we assessed whet er HO-1 was ca able of modulating the
ne expr ssion of th  selected HO-1 i te actors ( able 2, aste isks). Results showed that when PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expres ion profile of MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 




Biomolecules 2020, 10, x FOR PEER REVIEW 1  of 24 
reference group. HR: hazards ratio. N/A: not available. Genes selected for further analysis are 
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work showing a comparativ  RNA-seq analysis b twe n PC3 cel s over-
expressing HO-1 and co trols [8], w  found that HO-1 nducti n trigger d  alteration of key
cytoskeletal g es leadin  to a more adhesive and les nvasiv  ph notype, further supporti g it
anti-tumor l function in PCa [8]. Here, w  ass ssed wh ther -1 was ca able of modulati g th
gene ex ression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at w e  PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
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3.3. mRNA Expr ssion Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous work sh wing a comparative RNA-seq analysis b tween PC3 cells over-
expr ing -  a  o trols [8], w found that HO-1 inducti n triggered the alteration of key
cytoskeletal g es lead n  t  a more adhesive nd l s  nvasive phenotype, further supporti g its
anti-tumor l func ion in PCa [8]. Here, we as essed whet er -1 was ca able of modulating th
ne ex r ssio  of th  selected HO-1 i te ac ors ( able 2, aste isks). Results showed that w en PC3
cells were tra i tly tra sfect d w h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant ch nge n the expres ion profile of MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
.073 5.84 × 10−0 0. 04 0.49 (0.3–0.8)
SLC12A7
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highlighted with a white dot next to heir gene symbol. 
  EXPRESSI N SURVIVAL 




























4.2  ×  1.312 















, 35  
2  



















10−05  2.43 
.31  
































































































































3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previou work showing a comparativ  RNA-seq a alysis b twe n PC3 cel s over-
expressing HO-1 and co rols [8], w  found that HO-1 nducti n trigger d  alteration of key
cytoskelet l g es leading to a more adhesive an  les nv siv  ph otype, further supporti g it
anti-tumo l fu ction in PCa [8]. Here, w  ass s ed wh ther -1 was ca able f modul ti g th
gene ex ression of the selected HO-1 i teractors (Table 2, aste i ks). Results showed at w e  PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
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3.3. mRNA Expressi n P ofiles of HO-1 I erac or  u der Genetic I tion of HO-1
In our previous work sho ing a ative R -seq analysis between PC3 cells ver-
expressing HO-1 and controls [8], we fou d that HO-1 induction trigg red the alteration of key 
cytoskeletal genes leading to a more adhesive and less invasive phenotype, further supporting its 
anti-tumoral function in PCa [8]. Here, we assessed whether HO-1 was capable of modulating the 
gene expression of the selected  i ractors (Table 2, asterisks). Results showed that when PC3 
cells were transiently transfected with the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), the  was a significant cha ge in the exp ession profile f MX  (Figure 2A). The rest of 
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as d w regulated in PCa compared to normal gland a d was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
0.849 3.86 × 10−01 0. 01 0.39(0.19–0.65)
PURA *
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3.3. mRNA Expression Profiles of HO-1 Interactors nder Genetic I tion of HO-1 
In our previous work showing a comparative -seq analysis b tween PC3 cel s over-
expressing HO-1 and controls [8], we found that HO-1 nduction trigger d the alteration of key 
cytoskeletal gene  leading to a more adhesive and less invasiv  ph type, further supporting i  
anti-tumoral function in PCa [8]. Here, we ass ssed wh ther HO-1 was capable of modulating the 
gene expression of the selected  i ractors (Table 2, asteri ks). Results showed at when PC3
cells were transiently transfected with t e vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), the  was a significant cha ge in the xp ession profile f MX (Figure 2A). Th  rest of 
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as d wnregulated in PCa compared to normal gland a d was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
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(top 16%) 0. 31
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3.3. mRNA Expr ssi n Profiles of HO-1 Interac ors under Genetic I tion of HO-1 
In our previous work showing a comparativ R -seq analysis b tween PC3 cells over-
expressing -  a  ontrols [8], w  found that HO-1 induction triggered the alteration of key
cytoskeletal ge  leading o a more adhesive and less invasive phe type, further supporti g its
anti-tumoral func ion in PCa [8]. Here, we assessed whet er HO-1 was ca able of modulating the
gene expression of th  selected  i ractors (Table 2, aste isks). Results showed that when PC3
cells were tran i ntly tra sfect d wi h the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), the  was a si nificant cha ge in the exp es ion profile f MX1 (Figure 2A). The rest of
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as dow regulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
0.951 .87 × 1 −01 0. 01 0.41 (0.25–0.69)
RPA1
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3.3. mRNA Expression Profiles of HO-1 Interactors nder Genetic Induction of HO-1 
In our previous w rk showing a co parativ -seq analysis b twe n PC3 cel s ov r-
expressing HO-1 and controls [8], w  found that HO-1 nduction trigger d  alteration of key
cytoskeletal ge e  leading to a more adhesive and less invasiv  ph type, further supporti g i  
anti-tumoral function in PCa [8]. Here, w  ass ssed wh ther HO-1 was ca able of modulati g the
gene expression of the selected  i ractors (Table 2, aste i ks). Results showed at whe  PC3
cells were tran i ntly tra sfected with t e vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), the  was a si nificant cha ge in the exp ession profile f MX1 (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
2093
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previ u work sho ing a ative RNA-seq analysis between PC3 cells ver-
expr ssing HO-1 and co rols [8], we fou d that HO-1 induction trigg red the alteration of key
cytoskelet l g es leading t  a more adhesive an  less inv sive phe otype, further supporting its
anti-tumo al fu cti n in PCa [8]. Here, we as es ed whether HO-1 was capable f modulating the 
gene expressio  of the selected HO-1 interac ors (Table 2, asterisks). Results showed that when PC3 
cells were transiently transfected with the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), there was a significant change in the expression profile of MX1 (Figure 2A). The rest of 
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
1.246 5.39 × 1 − 6 0. 13 2 (1.16–3.47)
SFSR3
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3.3. mRNA Expression Profiles of HO-1 Interactors under Genetic Induction of HO-1 
In our previous w rk showing a co parativ R -seq a alysis b twe n PC3 cells ov r-
expressing HO-1 and co trols [8], w  found that HO-1 inducti n triggered  alteration of key
cytoskeletal g e  leadin  to a more adhesive and les  nvasive phe type, further supporti g i s
anti-tumor l function in PCa [8]. Here, w  assessed wh ther -1 was ca able of modul ti g th
gene ex ression of the selected  i ractors (Table 2, aste isks). Results showed that w e  PC3
cells were tran i ntly tra sfected with the vector pcDNA3HO-1 or the e pty vector as the contr l
(pcDNA3), there was a si nificant change in the expression profile of MX  (Figure 2A). The rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa co pared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
793
(top 11%) 0. 1 N/A . . . . . . 0.024 1.77 (1.08–2.91)
MX1 *
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3.3. mRNA Expression Pr files of HO-1 Interactors under Genetic Inducti n of HO-1 
In our previou w rk showing a co parativ RNA-seq a alysis b twe n PC3 cells ov r-
expressing HO-1 and co rols [8], w  found that HO-1 inducti n triggere  the alter tion of key
cytoskelet l g e  leading to a more adhesive an  les  nv sive phe type, further supporti g its
anti-tumo l fu ction in PCa [8]. Here, we asses ed whether -1 was ca able f modul ting th
gene ex ression of the selected HO-1 i teractors (Table 2, aste isks). Results showed that w en PC3
cells were tran i ntly tra sfected with the vector pcDNA3HO-1 or the empty vector as the control
(pcDNA3), there was a si nificant change in the expression profile of MX1 (Figure 2A). Th  rest of
the genes assessed presented no significant alteration under HO-1 induction. Interestingly, while 
MX1 appeared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 and Table 2), HO-1 modulation was capable of inducing its expression. 
1542
(top 19%) 0. 31
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3.3. mRNA Expr ssion Pr files of HO-1 Interactors under Genetic Induction of HO-1 
In our previ u w rk sh wing a ative RNA-seq analysis between PC3 cells ver-
expr ing -  a o rols [8], we found that HO-1 induction trigg red the alteration of key
cytoskelet l g s lead ng o a more adhesive n  l ss inv sive phe otype, further supporting its
anti-tumo al fu c i n in PCa [8]. Here, we as es ed whet er HO-1 was capable f modulating the 
ne expr ssio  of th  selected HO-1 inte ac ors ( able 2, asterisks). Results showed that when PC3 
cells were tra sie tly transfect d w h the vector pcDNA3HO-1 or the empty vector as the control 
(pcDNA3), the  was a significant ch ge n the exp es ion profile f MX1 (Figure 2A). The rest of 
the genes assessed p esented no significant al eration under HO-1 induction. Interestingly, while 
MX1 app ared as downregulated in PCa compared to normal gland and was associated with poorer 
RFS (Figure 1 nd Table 2), HO-1 modulation was capable of inducing its expression. 
0.578 1.04 × 1 − 7 0.0044 0.47 (0.28–0.80)
3.3. mRNA E ression Profiles of HO-1 Interactors un er Ge etic I duction of HO-1
In our previous work showing a comparative RNA-seq analysis between PC3 cells over-expressing
HO-1 and c ntrols [8], w f u d th t HO-1 in uction trigg ed the alt r tion of key cyt skeletal genes
l ad ng to m r adhesive nd less i vas v ph o ype, u th r sup orting its anti-tumoral function
in PCa [ ]. Here, we assessed whether HO-1 was capable of modulating the gene expression of the
s lect d HO-1 int r ctors (T ble 2, steri ks). R sults showed that when PC cells w re transiently
transfected with th v ctor pcDNA3HO-1 r h m ty vector as the control (pcDNA3), there was a
significant change in the expressio profil of MX1 (Figure 2A). The rest of the genes assessed presented
no significant alteration under HO-1 induction. Interestingly, while MX1 appeared as downregulated
Biomolecules 2020, 10, 1005 10 of 23
in PCa compared to normal gland and was associated with poorer RFS (Figure 1 and Table 2), HO-1
modulation was capable of inducing its expression.Biomolecules 2020, 10, x FOR PEER REVIEW 11 of 24 
 
Figure 2. Effect of HO-1 modulation on the expression and localization of MX1. (A) RNA-seq 
expression for the selected genes in Table 2 under HO-1 induction. PC3 cells were transiently 
transfected with the pcDNA3HO-1 expression plasmid or empty vector. Forty-eight hours later, RNA 
was extracted, purified, and sequenced. (B) MX1 assessed by real-time PCR (RT-qPCR) in PC3 cells 
treated with hemin (80 µM, 24 h) or PBS or transfected with the expression plasmids 
Figure 2. Effect of HO-1 modulation on the expression and localization of MX1. (A) RNA-seq expression
Biomolecules 2020, 10, 1005 11 of 23
for the selected genes in Table 2 under HO-1 induction. PC3 cells were transiently transfected with
the pcDNA3HO-1 expression plasmid or empty vector. Forty-eight hours later, RNA was extracted,
purified, and sequenced. (B) MX1 assessed by real-time PCR (RT-qPCR) in PC3 cells treated with
hemin (80 µM, 24 h) or PBS or transfected with the expression plasmids pcDNA3/pcDNA3HO-1 and
FLAG/FLAGHO-1. The values were relativized using PPIA as a reference gene and normalized to the
controls. (C) Immunofluorescence (IF) staining and confocal microscopy analysis (magnification: 60×)
for HO-1 (green) and MX1 (red) on PC3 cells transfected with the expression plasmids pcDNA3 or
pcDNA3HO-1. (D) Semi-quantitative analyses of the IF for MX1 by segmentation of the whole cell and
nucleus (DAPI). The fluorescence intensity for MX1 and HO-1 was determined using ImageJ software
and normalized to cell size (n ≥ 20 cells for each condition), and the ratios of nuclear label/total label
and total fluorescence/cell were calculated. (E) MX1 staining in the membrane, cytoplasm, and nucleus.
(F) Co-localization analysis of MX1 and HO-1 expressed as the Manders correlation coefficient. Error
bars correspond to the standard deviation. (G) HMOX1 and MX1 Pearson correlation analysis in
normal prostate (Genotype-Tissue Expression (GTEx) database, n = 100), normal adjacent to tumor, or
prostate cancer tissues (TCGA-PRAD, n = 52 and n = 497, respectively). One representative of at least
three independent experiments is shown. Results are shown as the mean ± S.D. Statistical significance:
** p < 0.01; *** p < 0.001.
Thus, we decided to focus our attention on the MX1 gene. First, we validated the RNA-seq
analysis by real-time PCR (RT-qPCR). PC3 cells treated with hemin, a potent inducer of HO-1, showed
a significant increase of MX1 expression (fold induction: 4.88, p < 0.01). Further, genetic induction of
HO-1 in PC3 cells, using two different expression vectors (pcDNA3HO-1 and FLAGHO-1), also caused
a significant increase in MX1 mRNA levels compared with cells transfected with empty vectors (fold
induction: 1.33, p < 0.01 and 3.91, p < 0.001, respectively) (Figure 2B).
3.4. Effect of HO-1 Modulation on the Expression and Localization of MX1
Subsequently, in order to assess whether the increase in MX1 was also reflected at the protein level
and whether it showed changes in its subcellular localization, we performed an immunofluorescence
analysis by confocal microscopy, using specific anti-MX1 and anti-HO-1 antibodies (Figure 2C). Results
showed that induction of HO-1 in prostate tumor cells caused a significant increase in MX1 protein
levels, observed by an enhancement in the total nuclei fluorescence and in the total cell fluorescence
compared with cells transfected with empty vector (Figure 2C–E). Furthermore, we were able to
determine by the Manders coefficient that there was a greater co-localization of HO-1 and MX1 when
cells over-expressed HO-1 (pcDNA3HO-1) compared with controls (Figure 2F, p < 0.001). Altogether,
HO-1 over-expression in PC3 cells triggered an increase in MX1 mRNA and protein levels and altered
its subcellular localization, reflecting a clear association between both proteins.
3.5. Correlation of Expression between MX1 and HMOX1 Genes in Normal Prostate and Prostate
Cancer Samples
We next assessed whether there was any correlation between MX1 and HMOX1 in tissues from
healthy donors and PCa patients. Using the TCGA-PRAD database, we observed a positive correlation
in the expression profiles of MX1 and HMOX1, both in normal adjacent to tumor (Pearson = 0.3718;
p = 0.0066) and in tumor tissue samples (Pearson = 0.4681; p < 0.0001) (Figure 2G). The MX1 and
HMOX1 correlation was not detected in normal tissue. This evidenced a potential association between
both genes in PCa.
3.6. Exome and RNA-Seq Correlation Analyses of MX1 and HMOX1 in Prostate Cancer
We extended the bioinformatics analysis, using cBioPortal for Cancer Genomics (https://www.
cbioportal.org). Eleven datasets were selected that met our eligibility criteria (Figure 3A). We assessed
whole exome and RNA-seq data to evaluate MX1 and HMOX1. This analysis performed on PCa patient
samples (n = 3211), showed that the most frequent gene alteration of MX1 was deletion (Figure 3B, left
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panel). It should be noted that for the TCGA-PRAD dataset, such an alteration reached a frequency of
13.21% (Figure 3B, left panel). Next, we analyzed whether there was a correlation between MX1 gene
alterations and its expression profile. Results showed that for the TCGA-PRAD dataset, those samples
with a complete MX1 deletion presented lower mRNA expression, compared with the unaltered
samples (diploid) (Figure 3B, right panel). The same analysis was carried out for HMOX1, and the
results showed that the most common alterations were amplification and deep deletion (Figure 3C,
left panel). However, the frequency of alterations in PCa patients was substantially lower (0.6%)
compared with MX1 (14%) (Figure 3B,C). Additionally, while most of the samples presented the two
copies of HMOX1, only a smaller proportion of the samples showed superficial deletion (shallow
deletion) without it being associated with a lower level of mRNA expression (Figure 3C, right panel).
In summary, in silico analysis showed that PCa patients with MX1 deletion correlated with lower MX1
mRNA levels.
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cBioPortal for the genetic alterations’ analysis in MX1 and HMOX1 in PCa patients. The table shows
the number of samples and the number of patients with alterations in target genes. (B,C) (left panels):
Percentage of cases with alterations and the type of alteration observed: Point mutations (green),
amplifications (red), fusion (purple), or complete deletions (blue) for MX1 (B) and HMOX1 (C), through
11 selected dataset (x-axis). Right panels: correlation between gene expression and copy number
alterations for MX1 (B) and HMOX1 (C) in TCGA-PRAD (n = 333). Statistical significance: ** p < 0.01;
*** p < 0.001. N/A = not available.
3.7. MX1 and Endoplasmic Reticulum Stress in Prostate Cancer
Taking into account the results observed so far, the next step was to explore in PCa the
possible functional role of MX1, the main IFN-inducible gene, and its association with ERS and
with ERS-mediated apoptosis.
To address this goal, we generated ERS conditions in the tumor cells using a specific ERS
inducer, thapsigargin. This drug inhibits the proper functioning of the sarco-/endo-plasmic reticulum
Ca++-ATPase. This inhibition generates an imbalance in the Ca2+ ion homeostasis, which triggers
ERS signaling [25]. In this work, we studied the expression of X-box binding protein 1 (XBP1), which
participates downstream of the IRE1 activator; DNA damage inducible transcript 3 (DDIT3), a gene
coding for the protein inducible by DNA damage and growth arrest (CHOP); and heat shock protein
family A (Hsp70) member 5 (HSPA5), a gene encoding for BiP. This chaperone is the main activator of
the ERS pathway [26]; therefore, an increase in HSPA5 levels is considered a strong ERS marker [10].
PC3 cells treated with thapsigargin showed a significant increase in HSPA5 mRNA expression
compared with the control (fold induction: 4.71, p < 0.001 and 9.41, p < 0.001, for 0.1 µM and
0.25 µM, respectively) (Figure 4A). Similarly, we could see a significant increase in mRNA levels
of the UPR intermediate genes, DDIT3 (fold induction: 8.21, p < 0.001 and 8.46, p < 0.001, 0.1 µM
and 0.25 µM, respectively) and XBP1 (fold induction: 5.17, p < 0.001 and 8.13, p < 0.001, 0.1 µM or
0.25 µM, respectively) (Figure 4A). These results demonstrated that ERS was triggered in PC3 cells in a
thapsigargin concentration-dependent manner. We also assessed MX1 expression under ERS induction.
Results showed increased MX1 mRNA levels compared with controls under thapsigargin treatment
(fold induction: six, p < 0.01 and 7.4, p < 0.01, 0.1 µM or 0.25 µM, respectively) (Figure 4A). In summary,
we reported MX1 induction under ERS conditions, something not previously described in PCa.
We also confirmed MX1 induction under IFNγ treatment (fold induction: 16.79, p < 0.001)
(Supplementary Figure S2A). Since thapsigargin not only triggered an increase in ERS, but also
generated an induction of MX1 expression in PC3 cells, this led us to hypothesize if those conditions
that raised MX1 levels, such as hemin or IFNγ, were capable of inducing the expression of ERS genes.
The results showed that IFNγ treatment caused a significant increase in DDIT3, XBP1, and HSPA5
expression (Supplementary Figure S2B). On the other hand, when treating PC3 cells with hemin,
a significant decrease in DDIT3 and HSPA5 expression was observed compared with controls. No
change in XBP1 expression was observed (Supplementary Figure S2C). These results indicated that
hemin reduced the basal levels of ERS, contributing to reverse the state of cellular ERS.
Further, we knocked down MX1 using MX1 small interfering RNA (siMX1). As expected,
thapsigargin-induced levels of MX1 were significantly decreased by siMX1 (75%, p < 0.001) (Figure 4B).
Moreover, a significant decrease by siMX1 was also observed for HSPA5 (19.64%, p < 0.01), DDIT3
(26.93%, p < 0.05), and XBP1 (24.19%, p < 0.01), relativized to the transfection control (thapsigargin +
scrambled) (Figure 4B). In summary, these results showed that MX1 could regulate these genes under
ERS conditions.
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(A) HSPA5, DDIT3, XBP1, and MX1 expression assessed by RT-qPCR in PC3 cells treated with
thapsigargin (0.1 and 0.25 µM; 24 h) or PBS as the control. Values were relativized using PPIA as a
reference gene and normalized to the control. (B) MX1, HSPA5, DDIT3, and XBP1 expression levels
assessed by RT-qPCR in PC3 cells transfected with a MX1-targeted siRNA or a scrambled siRNA for
72 h and treated with 0.25 µM thapsigargin during the last 24 h of silencing. Values were relativized to
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PPIA as a reference gene and normalized to the control. (C) Flow cytometry graphs showing cell
viability and apoptosis populations in PC3 cells treated with thapsigargin (0.1 and 0.25 µM; 24 h) or
PBS as the control. Cells were treated with FITC-labeled Annexin V and PI staining. X axis: FITC
channel; Y axis: PI channel. (D) LC3 I and LC3 II protein levels assessed by Western blot in PC3 cells
treated with thapsigargin (0.1 and 0.25 µM; 24 h) or PBS as the control. Protein bands were quantified
using ImageJ 1.52a software (NIH), normalized to GAPDH as a reference protein, and relativized to the
control (right panel). One representative of at least three independent experiments is shown. Results
are shown as the mean ± S.D. Statistical significance: * p < 0.05; ** p < 0.01, *** p < 0.001.
3.8. Effect of Thapsigargin-Induced Endoplasmic Reticulum Stress in Apoptosis and Autophagy in
Prostate Cancer
We then evaluated whether ERS induction affected cellular processes such as apoptosis and
autophagy. For this purpose, we performed flow cytometry analysis (Annexin V-FITC/IP) on PC3
cells, exposed to thapsigargin. The results clearly showed that this compound was able to trigger
a significant increase in apoptosis compared with the control (Figure 4C). As observed earlier, cells
grown in the presence of thapsigargin showed high levels of ERS and MX1 induction.
Faced with a stimulus that triggers ERS, cells seek to reestablish homeostasis through the UPR
signaling pathway. Autophagy is considered one of the highly characterized effectors of the UPR
pathways. For this reason, we also analyzed the implication of this cellular process under ERS
conditions in PCa. We assessed LC3 lipidation, indicated by the conversion of LC3-I into LC3-II.
The results showed that endogenous levels of LC3-II accumulated upon thapsigargin treatment
compared with controls (Figure 4D). These results supported the ideas that propose autophagy as an
effector pathway of UPR once ERS is triggered in the cell.
3.9. Analysis of HMOX1, MX1, and Endoplasmic Reticulum Stress Genes as Risk Predictors of Clinical
Outcome in Prostate Cancer
We next analyzed whether the alteration in HMOX1, MX1, and ERS genes’ expression could
influence PCa patients’ RFS. Kaplan-Meier curves for the Ross–Adams dataset (GSE70770, n = 206)
showed that higher expression levels for both MX1 and HMOX1 were associated with a better RFS in
PCa patients (HR = 0.47, p = 0.0044 for MX1 and HR = 0.50, p = 0.021 for HMOX1) (Figure 5A).
Next, we assessed the association between the expression profiles of HMOX1 and MX1 in the same
dataset. In accordance with the TCGA-PRAD dataset (Figure 2G), we observed a positive correlation
between HMOX1 and MX1 expression (Pearson = 0.4865, p < 0.0001) (Figure 5B).
Next, we categorized PCa patients based on MX1 expression and performed KM curves to evaluate
the effect of HMOX1 in RFS of these patient subgroups (low or high MX1 expression). Interestingly,
while it was observed that patients with low MX1 had a higher risk of biochemical relapse (Figure 5A),
this risk decreased significantly in those patients who exhibited higher levels of HMOX1 (HR = 0.13;
p = 0.048) (Figure 5C, left panel). In contrast, the expression profile of HMOX1 did not seem to
influence the risk of biochemical relapse in those patients with high levels of MX1 (HR = 0.6; p = 0.253)
(Figure 5C, right panel). We then expanded the analysis for HSPA5 and DDIT3 and found similar
results to those observed for MX1 and HMOX1. Patients with higher expression for ERS genes showed
a significantly lower risk of relapse than patients with lower expression for these genes (Figure 5D;
HR = 0.23, p < 0.0001 for HSPA5 and HR = 0.49, p = 0.008 for DDIT3). We also evaluated the effect of
co-occurrent high expression for all genes. It is interesting to note that patients with high expression of
two or more factors (MX1, HMOX1, HSPA5, or DDIT3) had a lower risk of biochemical relapse than
patients with one or none of the highly expressed genes (HR = 0.36; p < 0.001) (Figure 5E).
These results suggested that higher levels of MX1, HMOX1, DDIT3, and HSPA5 resulted in a
better prognosis for PCa patients that have undergone radical prostatectomy.
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RFS for PCa patients with high (red) or low (blue) expression of HMOX1 segregated based on low (left
panel) or high (right panel) MX1 levels. (D) KM curves for RFS for PCa patients with high (red) or
low (blue) expression of HSPA5 (left panel) or DDIT3 (right panel). (E) KM curve for the co-occurrent
expression of MX1, HMOX1, HSPA5, or DDIT3 in patients with two or more (red) or one/none (blue)
highly expressed genes. All comparisons considered low expression patients as the reference group.
HR: hazards ratio. Statistical significance: p < 0.05.
4. Discussion
The induction of HO-1 represents an essential event in cellular responses to pro-oxidative and
pro-inflammatory insults maintaining cellular homeostasis [1]. Thus, HO-1 has been proposed to act
as a biosensor regulating cell destination [27]. Our previous reports have documented the nuclear
expression of HO-1 in human primary prostate carcinomas naive of treatment [28]. We also showed
that HO-1 is further implicated in PCa, demonstrating that endogenous HO-1 inhibits bone-derived
prostate cancer cell migration, invasion, and proliferation [4] and negatively modulates the expression
of pro-inflammatory and pro-angiogenic genes. Further, using a fully immunocompetent murine
model, our reports revealed how stromal conditioning with hemin impaired PCa development by
targeting both the tumor vasculature and the cytotoxic T-cell immune response [29]. These data,
together with the reported bibliography, clearly suggest that HO-1 fulfills a key molecular and cellular
function, beyond its enzymatic function.
It seems as if HO-1 could suppress the sustained inflammation in PCa, halting tumor
progression [4,5]. However, it is logical to think that this anti-tumoral action directed by HO-1
is associated with other factors capable of interacting with HO-1 to carry out these functions. Hence,
we sought to analyze the HO-1 interactome in PCa to unravel some of the molecular mechanisms
underlying its anti-tumoral role and the acquisition of a less aggressive phenotype in PCa. In our
previous work, we optimized the purifying technique to isolate HO-1 interacting proteins in PCa
cells and build the HO-1 interactome. This provided a framework for identifying novel partners that
could reprogram PCa cells, favoring the less aggressive tumor phenotype observed under HO-1 forced
expression [4,5,8,30].
Although we studied prostate tumor tissues at the transcriptomic level, proteins involved in
tumor evolution have been less explored in PCa. Different groups of genes, proteins, and metabolites
are responsible for the progression from a precursor lesion to a localized disease and finally leading to a
metastatic stage. To understand the clinical-pathological importance of proteins associated with HO-1,
we carried out an in-depth bioinformatics analysis (Oncomine, n = 1045) using public datasets that
allowed us to assess their clinical relevance in the disease. HO-1 interactor proteins were analyzed, and
an expression profile was elaborated for each one of them. We clustered interactors according to their
mRNA expression profiles in three groups, highlighting those genes that were over- or under-expressed
in approximately >60% (Cluster A) or 50% (Cluster B) of all datasets in prostate adenocarcinoma vs.
normal prostate gland and lied within 35% of the most consistently high or low expressed genes across
this comparison. In parallel, we studied the expression of HO-1 interactors in TCGA-PRAD, which has
information on gene expression in 497 primary PCa tumor samples compared with normal adjacent to
tumor tissue.
Although the comparisons made in TCGA-PRAD and Oncomine were not exactly on the same
tissues, a similarity could be observed between the expression profiles obtained in both analyses for
most of the genes studied. Likewise, we evaluated the protein expression of these genes using The
Human Protein Atlas database, in tumor and normal tissue samples. The protein profiles observed in
this platform for most of the HO-1 interactors correlated with those already observed at the mRNA
level in the datasets analyzed in Oncomine and TCGA-PRAD, thus evidencing that the expression
profile of HO-1 interactors in PCa is dysregulated at the transcriptomic and protein levels.
Our next aim was to evaluate the risk of relapse associated with the expression of the genes of
interest in PCa patients who had undergone radical prostatectomy. Results showed that upregulation
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of RCC1 and PDCD5 and downregulation of ASPH, HSPB1, SQSTM1, ANXA2, GSN, PURA, and MX1,
comparing PCa vs. normal prostate or normal adjacent to tumor tissue, correlated with a decrease in
relapse-free survival of PCa patients, revealing the clinical importance of the HO-1 interactors classified
into Groups A or B.
In order to assess whether HO-1 was capable of modulating its interactors at the transcriptional
level, we evaluated the transcriptomic profile of PC3 cells under genetic induction of HO-1 by RNA-seq.
We paid special attention to MX1, since HO-1 modulation was capable of inducing MX1 expression.
Altogether, the evidence obtained from the different analyses performed led us to focus on MX1, since:
(1) it showed a significant over-expression under HO-1 induction; (2) it was under-expressed in PCa vs.
normal prostate; and (3) its low expression was associated with a significant decrease in RFS for PCa
patients. Further, there was a significant positive correlation between MX1 and HMOX1 expression in
PCa patients.
Little is known about MX1 and its association with tumorigenesis. Mushinski et al. [31] explored
the molecular mechanisms of PCa metastasis using PC3 and PC3M (derived from a liver metastasis
from a nude mouse bearing a splenic explant of PC3) cell lines. Results showed that MX1 was expressed
in PC3 and not in PC3M. Further, it was demonstrated that MX1 transcription was inducible by type I, II,
and III IFNs [32–34]. Both, type I and II IFNs have been used in the treatment of various types of cancer,
including melanoma, follicular lymphoma, hairy cell leukemia, chronic myeloid leukemia, Kaposi’s
sarcoma, and renal cell carcinoma, but the mechanisms of their anti-tumoral activity have not been
fully deciphered [35]. Direct anti-proliferative effects on the tumor and indirect immunomodulatory
effects on the host have been reported for type I and II IFNs. Shou et al. [36], Nagano et al. [33],
and Schulz et al. [37] demonstrated that a significant proportion of genes whose downregulation is
associated with PCa tumorigenesis were IFN-inducible genes, including MX1. However, MX1 has
been mostly studied for its antiviral properties [14–16]. To test the hypothesis that MX1 played a role
in reducing the motility and metastasis of PCa and other cancers, Mushinski et al. [31] over-expressed
MX1 in PC3M and LOX melanoma cells. MX1 over-expression induced a clear reduction in motility
and invasiveness in both cell lines compared with controls. Similarly, in vivo assays in SCID mice
showed a significant reduction of liver metastases after intra-splenic injection of PC3M cells expressing
MX1 [31].
As shown in this study, genetic or pharmacological induction of HO-1 was able to induce MX1
expression. Moreover, immunofluorescence assays revealed a significant increase in MX1 intensity
under HO-1 induction. Interestingly, increased co-localization of HO-1 and MX1 was observed when
cells over-expressed HO-1 compared with controls. Taking these results into account, we evaluated
whether there was any correlation between these two genes in PCa patient tissues. The results
evidenced a significant positive correlation between MX1 and HMOX1 expression profiles, both in
human tumor and normal adjacent to tumor tissue samples. No correlation was observed in normal
tissue samples, which highlights a potential association between both factors in prostate tumor tissues.
In 2008, Tomlins et al. first reported that approximately 50% of PCa cohorts had a fusion between
TMPRSS2 and ERG on chromosome 21 [38], which correlated with an invasive phenotype and was
frequently associated with interstitial DNA deletions spanning the MX1 locus [39]. These deletions
are associated with an increase in PCa aggressiveness. In this work, we also analyzed whether there
were genetic alterations in MX1 associated with PCa and whether these alterations were related to
the decreased expression profile seen in the disease. The cBioPortal platform, which included studies
of RNA-seq and copy-number alterations for PCa patient samples (n = 3211), showed that deletion
was the most frequent genetic alteration in MX1. Subsequently, we analyzed whether there was a
correlation between MX1 copy number alterations and its expression profile. Results evidenced that
samples with a complete deletion for MX1 displayed decreased mRNA expression. The same analysis
was carried out for HMOX1, in which deletions were rarely observed throughout the samples, without
it being associated with decreased HMOX1 mRNA levels.
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As mentioned before, MX1 plays an important role in anti-viral activity [14–16]. Previous
literature reported the association between viral infection and regulation of ERS [40]. Numajiri et al.
demonstrated that MX1 potentiates ERS signaling and ERS-induced cell death after Swiss 3T3 cells (cell
line derived from mouse embryo fibroblasts) were infected with the Influenza virus [41]. Furthermore,
MX1 induction increased HSPA5 (BiP) and DDIT3 (CHOP) mRNA levels and XBP1 alternative splicing,
leading to the expression of genes involved in endoplasmic reticulum degradation and cell death [41].
Therefore, MX1 may function as an accelerator of ERS-mediated apoptosis.
Hence, we set out to analyze the role of MX1 in ERS, UPR pathways, and ERS-associated apoptosis
in PCa. UPR activation is considered the criterion that defines ERS [10]. This mechanism aims to
safeguard cell survival against injury or initiate cell apoptosis in cases of excessive stress. To address
this goal, we generated ERS using thapsigargin, which was confirmed by a significant induction
of HSPA5, DDIT3, and XBP1. MX1 was also significantly induced under ERS, and strikingly, MX1
silencing was able to decrease thapsigargin-induced ERS significantly, mainly evidenced by HSPA5
downregulation. Further, we evaluated the effect of ERS on apoptosis and autophagy. Results showed
that, under ERS stimulus, apoptosis and autophagy significantly increased in PC3 cells.
Considering that HMOX1 was able to modulate MX1, we proposed to study whether the alteration
of MX1, HMOX1, and ERS genes’ expression could alter the biochemical RFS of PCa patients. Results
showed that an increase in MX1, HMOX1, DDIT3, and HSPA5 expression reduced the risk of biochemical
relapse in PCa patients who had undergone radical prostatectomy. Additionally, patients with a
higher risk of relapse due to low MX1 expression, had a better prognosis with higher HMOX1 levels.
This work is the first to associate HMOX1, MX1, and ERS in PCa.
The toxicity caused by the accumulation of misfolded proteins can be so severe for the cell that
UPR has evolved as the main mechanism to deal with this threat, and depending on the intensity and
duration of stress, UPR can tip the balance towards cell survival or death [10]. When cells experience
a mild to moderate stress signal with a short duration, UPR activates the pro-survival module that
seeks to neutralize the initial stress so that cells can adapt to it. Conversely, if the stress signal is
intense and/or lasts over time, the UPR activates the pro-death module, which aims to lead the cell to
apoptosis [26].
The pro-survival module is well represented by BiP [10], which is encoded by HSPA5. The pro-death
module is represented by CHOP, encoded by DDIT3 (Figure 6A). In the absence of stress, the BiP
chaperone is associated with transmembrane sensors: Endoplasmic reticulum pancreatic kinase (PERK),
enzyme 1 with inositol requirement (IRE1), and factor 6 transcription activator (ATF6). The UPR
mechanism starts when the BiP chaperone is sequestered by the misfolded proteins that begin to
accumulate in the reticular lumen [26]. This event causes the release of the transmembrane sensors
IRE1, ATF6, and PERK from the ER, triggering the activation of UPR, ultimately determining cell fate
(Figure 6A).
Reports have evidenced that: (1) MX1 improves ERS signaling via CHOP induction and promotes
ERS-mediated apoptosis [41]; (2) the C-terminal region of MX1 is critical for interaction with BiP [42];
and (3) our results showed that MX1 silencing directly decreases DDIT3 expression; therefore, we may
suggest that MX1 over-expression causes BiP sequestering, enhancing PERK-mediated pathway
activation, leading to cell death (Figure 6B). Further, HO-1 may favor this ERS axis, enhancing MX1
levels, tilting the balance to pro-death events in PCa.
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